1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline
C51H32N4S — CID 164927986
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline
1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline (PubChem CID 164927986) has the molecular formula C51H32N4S and a molecular weight of 732.91 g/mol. Its IUPAC name is 1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline.
Molecular Properties
| Compound Name | 1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline |
|---|---|
| PubChem CID | 164927986 |
| Molecular Formula | C51H32N4S |
| Molecular Weight | 732.91 g/mol |
| Exact Mass | 732.23 |
| IUPAC Name | 1-[4-(4-dibenzothiophen-4-yl-6-phenylpyrimidin-2-yl)phenyl]-2,5-diphenylpyrazolo[5,1-a]isoquinoline |
| SMILES | c1ccc(-c2cc(-c3cccc4c3sc3ccccc34)nc(-c3ccc(-c4c(-c5ccccc5)nn5c(-c6ccccc6)cc6ccccc6c45)cc3)n2)cc1 |
| InChI | InChI=1S/C51H32N4S/c1-4-15-33(16-5-1)43-32-44(42-25-14-24-41-40-23-12-13-26-46(40)56-50(41)42)53-51(52-43)37-29-27-35(28-30-37)47-48(36-19-8-3-9-20-36)54-55-45(34-17-6-2-7-18-34)31-38-21-10-11-22-39(38)49(47)55/h1-32H |
| InChIKey | LOCLKKZXAJPRCT-UHFFFAOYSA-N |
| XLogP | 13.65 |
| TPSA | 43.08 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 732.91 |
| LogP ≤ 5 | 13.65 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164927986 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.